Sheila A Lukehart Selected Research

Reagins

1/2021	Analytical Performance Characteristics of a New Transcription-Mediated Amplification Assay for Treponema pallidum.
12/2017	Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study.
4/2016	Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.
4/2014	Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study.
10/2008	Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis.
2/2006	Comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma reagin test for antenatal syphilis screening in Mozambique.
4/2004	Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter?
2/2004	Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheila A Lukehart Research Topics

Disease

28	Syphilis 01/2022 - 07/2002
21	Infections 12/2021 - 07/2002
9	Yaws 01/2022 - 01/2014
6	Neurosyphilis (General Paresis of the Insane) 01/2018 - 02/2004
3	secondary Syphilis 01/2021 - 09/2015
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2017 - 04/2004
1	Treponemal Infections (Bejel) 01/2022
1	Skin Ulcer 12/2021
1	Ulcer 12/2021
1	Latent Syphilis 01/2021
1	Exanthema (Rash) 09/2015
1	Chancre 12/2014
1	Congenital Syphilis (Hutchinson's Teeth) 03/2014
1	Periodontitis 02/2004
1	Reinfection 10/2003
1	Relapsing Fever 08/2003
1	Lyme Disease (Disease, Lyme) 08/2003
1	Leptospirosis 08/2003

Drug/Important Bio-Agent (IBA)

9	Azithromycin (Zithromax)FDA LinkGeneric 12/2021 - 02/2006
8	VaccinesIBA 12/2021 - 10/2003
8	ReaginsIBA 01/2021 - 02/2004
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
7	AntibodiesIBA 12/2014 - 12/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
5	MacrolidesIBA 12/2021 - 02/2006
3	AntigensIBA 12/2014 - 08/2003
2	EpitopesIBA 01/2022 - 12/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2021 - 06/2015
2	RNA (Ribonucleic Acid)IBA 09/2017 - 05/2010
2	Ribosomal DNA (rDNA)IBA 01/2016 - 12/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2014 - 12/2011
2	Biological ProductsIBA 12/2011 - 01/2006
2	Messenger RNA (mRNA)IBA 06/2007 - 01/2007
2	CytokinesIBA 06/2007 - 04/2007
2	protein KIBA 10/2003 - 07/2002
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2022
1	Immune Sera (Antisera)IBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 12/2021
1	16S Ribosomal RNAIBA 12/2021
1	Nucleic AcidsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	23S Ribosomal RNAIBA 01/2018
1	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2016
1	Poly GIBA 06/2015
1	Fibrinolysin FDA Link 04/2014
1	Penicillins (Penicillin)FDA Link 03/2014
1	Chemotactic FactorsIBA 05/2010
1	LigandsIBA 05/2010
1	CXC ChemokinesIBA 05/2010
1	Interferon-gamma (Interferon, gamma)IBA 06/2007
1	Interleukin-4 (Interleukin 4)IBA 06/2007
1	Interleukin-10 (Interleukin 10)IBA 06/2007
1	Interleukin-2 (IL2)IBA 06/2007
1	Coloring Agents (Dyes)IBA 02/2006
1	Virulence Factors (Pathogenicity Factors)IBA 11/2004
1	ImmunosorbentsIBA 11/2004
1	EnzymesIBA 11/2004
1	Dinoprostone (PGE2)FDA Link 02/2004
1	Protein Sorting Signals (Signal Peptide)IBA 11/2003
1	Thomsen-Friedenreich antibodiesIBA 08/2003
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2002
1	Peptides (Polypeptides)IBA 07/2002

Therapy/Procedure

3	Mass Drug Administration 12/2021 - 12/2017
3	Therapeutics 12/2021 - 04/2004
3	Aftercare (After-Treatment) 05/2010 - 04/2004
1	Ligation 02/2004